Stock Information

Markets
TSX21205.16-69.41
TSXV900.87+10.01
DOW35028.65-339.82
S&P 5004532.76-44.35
NASD14340.26-166.64
ASX7408.80-8.50
Commodities
Gold1842.67+4.26
Silver24.11+0.03
Copper4.46-0.01
Palladium1998.30+17.80
Platinum1024.00+7.00
Oil86.00-0.96
Heating Oil2.61-0.03
Natural Gas4.00-0.03
Currencies
BTCUSD41724.36-63.38
USDCAD1.2504-0.0007
USDEUR0.8802-0.0014
USDGBP0.7335-0.0013
USDAUD1.3798-0.0060
USDJPY114.05-0.30

Martha Stewart CBD Launches its First-Ever Category Expansion with New Line of CBD Wellness Topicals

New Super Strength CBD Cream, Sleep Science CBD Cream and Daily De-Stress CBD Cream Add to Martha's Wellness Portfolio

 Today, Martha Stewart CBD unveiled Martha Stewart CBD Wellness Topicals, marking the brand's first-ever category expansion in its growing CBD portfolio. Martha Stewart CBD provides consumers with an easy way to manage their needs throughout the day with convenient and trusted CBD products including gummies, oils, softgels and the new CBD Wellness Topicals. Martha Stewart CBD Wellness Topicals offer simple solutions that are easy to use, easy to love, and are a part of Martha's wellness portfolio.

Keep reading... Show less

Canopy Growth Issues Environmental, Social, and Governance Report

The inaugural report details the Company's commitment to building a responsible and sustainable organization defined by purpose

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced the release of its Environmental, Social, and Governance (ESG) Report ("the Report") for calendar year 2020, as well as qualitative details on some key activities that occurred in 2021.  The Report recognizes Canopy's current progress and describes its priorities and approach to ESG as part of its long-term path towards responsible and sustainable growth.

Keep reading... Show less

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Sale supports the Company's strategic focus on driving demand for cannabis and cannabinoid-based consumer products

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH ("C3"), to Dermapharm Holding SE ("Dermapharm") (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany . The C³ business develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany THC Pharm GmbH The Health Concept, based in Frankfurt, Germany and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria .

Keep reading... Show less
×